inhibition curve (three parameters) analysis option Search Results


3 parameter dose response inhibition function  (GraphPad Software Inc)
90
GraphPad Software Inc 3 parameter dose response inhibition function
3 Parameter Dose Response Inhibition Function, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3 parameter dose response inhibition function/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
3 parameter dose response inhibition function - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
inhibition curve (three parameters) analysis option  (GraphPad Software Inc)
90
GraphPad Software Inc inhibition curve (three parameters) analysis option
(A) Initial screening of PLpro <t>inhibition</t> by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.
Inhibition Curve (Three Parameters) Analysis Option, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/inhibition curve (three parameters) analysis option/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
inhibition curve (three parameters) analysis option - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


(A) Initial screening of PLpro inhibition by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.

Journal: bioRxiv

Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

doi: 10.1101/2021.06.04.447160

Figure Lengend Snippet: (A) Initial screening of PLpro inhibition by 33 deubiquitinase inhibitors. (B) Initial screening of PLpro inhibition by 37 cysteine protease inhibitors. Reaction conditions: 20 nM PLpro, 50 μM Z-LRGG-AMC, 200 μM inhibitor, 20 mM Tris-HCl, 300 mM NaCl, pH 7.5.

Article Snippet: The normalized PLPro activity against drug concentration was analyzed with the inhibition curve (three parameters) analysis option in GraphPad 8.0 to determine the IC 50 values.

Techniques: Inhibition

IC 50 characterizations for 16 small molecules on their inhibition of PLpro using 50 μM LRGG-AMC as a substrate. Experiments at different conditions were performed in triplicates.

Journal: bioRxiv

Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

doi: 10.1101/2021.06.04.447160

Figure Lengend Snippet: IC 50 characterizations for 16 small molecules on their inhibition of PLpro using 50 μM LRGG-AMC as a substrate. Experiments at different conditions were performed in triplicates.

Article Snippet: The normalized PLPro activity against drug concentration was analyzed with the inhibition curve (three parameters) analysis option in GraphPad 8.0 to determine the IC 50 values.

Techniques: Inhibition

IC 50 assays for 6 deubiquitinase inhibitors on their inhibition of 20 nM PLpro using 5 μM Ub-AMC as substrate. Experiments at different conditions were performed in triplicates.

Journal: bioRxiv

Article Title: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease

doi: 10.1101/2021.06.04.447160

Figure Lengend Snippet: IC 50 assays for 6 deubiquitinase inhibitors on their inhibition of 20 nM PLpro using 5 μM Ub-AMC as substrate. Experiments at different conditions were performed in triplicates.

Article Snippet: The normalized PLPro activity against drug concentration was analyzed with the inhibition curve (three parameters) analysis option in GraphPad 8.0 to determine the IC 50 values.

Techniques: Inhibition